-
2023-507633-21-00
5
Neurological Disease
-
2022-502779-40-99
5
Primary prevention of atherosclerotic cardiovascular disease (ASCVD)
-
2022-500631-36-00
5
Focal cerebral arteriopathy and childhood stroke
Focal cerebral arteri
-
2023-505500-37-00
5
Pregnant women with singleton pregnancies hospitalized for threatened
-
2023-506420-93-00
4
Chronic recurrent multifocal osteomyelitis (CRMO)
-
2023-507010-27-00
5
Primary Bilateral Macronodular Adrenal Hyperplasia causing moderate Cu
-
2023-508062-15-00
5
Primary Hyperoxaluria (PH) of all subtypes (PH1, PH2 and PH3)
-
2023-508658-24-00
4
type B3 thymoma and thymic carcinoma
-
2024-511114-20-00
5
Craniopharyngioma
-
2024-511880-27-00
4
Newly diagnosed Glioblastoma (IDH wild-type) patients at initial radio
-
2024-514246-37-00
4
Idiopathic pulmonary fibrosis (IPF)
-
2024-515439-31-00
5
Alopecia areata
-
2024-515663-59-00
5
intracerebral haemorrhage
-
2024-516335-27-00
5
anti-MAG neuropathy
-
2024-517187-36-01
10
Dominantly Inherited Alzheimer’s Disease (DIAD)
-
2024-517310-15-00
3
Parkinson's Disease
-
2024-517769-17-00
4
Poor prognosis cervico-facial lymphatic malformations (Lymphangima)
-
2024-518018-22-00
5
staphylococcal endocarditis
-
2024-518146-25-00
5
patients with atrial fibrillation and preserved left ventricular eject
-
2024-518835-13-00
5
Suspected Vascular Disease of supra-aortic (carotid/vertebrobasilar),
-
2024-519133-29-00
4
Focal epilepsy
-
2024-519655-28-00
5
Premenopausal patients with high-risk HR-positive/HER2-negative breast
-
2024-520131-33-00
4
atrial fibrillation
-
2024-520414-21-00
5
Adult patients with a LVOS with large core within 9 hours of symptoms